Abstract
MCL-467 Glofitamab Monotherapy Induces High Complete Response Rates in Patients With Heavily Pretreated Relapsed or Refractory Mantle Cell Lymphoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have